Korean J Obstet Gynecol Search


Korean Journal of Obstetrics & Gynecology 2005;48(10):2261-2284.
Published online October 1, 2005.
Consolidation and maintenance therapy for patients with advanced epithelial ovarian cancer.
Seung Cheol Kim
Department of Obstetrics and Gynecology, Ewha Women's University, College of Medicine, Seoul, Korea. onco@ewha.ac.kr
The current therapy for patients with advanced ovarian cancer consists of maximal cytoreductive surgery followed by six cycles of combination chemotherapy with paclitaxel/carboplatin. With this therapy, approximately 75% of patients with advanced epithelial ovarian cancer will achieve a clinical complete remission (normal CT, normal CA-125, normal pelvic exam), but the majority of patients will recur. Therefore, the strategy to consolidate and to prolong the duration of response is very important because cure for patients with recurrent disease is highly improbable. Several treatments for consolidation/maintenance have been attempted, such as whole abdominal radiation, intraperitoneal chromic phosphate, radioimmunotherapy, intraperitoneal chemotherapy, high-dose chemotherapy with hematopoietic support, prolonged administration of the first-line regimen, second-line single-agent chemotherapy, and biological agents. Unfortunately, many clinical studies have been conflicting, inconclusive, and generally disappointing. Recently, the GOG, together with SWOG, showed that prolonged treatment with single-agent paclitaxel (175 mg/m2 every 4 weeks) significantly improved the progression- free survival of complete responders to paclitaxel/platinum-based chemotherapy. Alternative less toxic, and more effective schedules of administration of chemotherapy (i.e. weekly paclitaxel) might provide a better balance between quality of life and anti-tumor activity in patients previously exposed to chemotherapy.
Key Words: Epithelial ovarian cancer, Consolidation, Maintenance, Therapy

Article category

Browse all articles >


Browse all articles >

Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea
Tel: +82-2-3445-2382    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2020 by Korean Society of Obstetrics and Gynecology. All rights reserved.

Developed in M2community

Close layer
prev next